Skip to main content
. 2022 Mar 23;227(4):488–497. doi: 10.1093/infdis/jiac108

Figure 2.

Figure 2.

Age-specific prevalence of anal and cervical human papillomavirus (HPV)16 and high-risk (HR)-HPV infection in human immunodeficiency virus (HIV)-negative women and women with HIV: (A) HPV16 prevalence in HIV-negative women; (B) HPV16 prevalence in women with HIV; (C) HR-HPV prevalence in HIV-negative women; (D) HR-HPV prevalence in women with HIV. Error bar = 95% confidence interval. Significant prevalence ratios (PRs) relative to the reference group are shown in bold. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68.